Skip to main content
    X

    XWELL Inc. (XWEL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.53
    -0.03 (-5.42%)

    Market Cap: $5.62M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    XWELL Inc. (XWEL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to XWELL are bioAffinity Technologies (BIAF), MDxHealth SA (MDXH) and iSpecimen (ISPC). By market cap, XWELL ranks 5th of the 13 companies on this page; Precipio (PRPO) is the largest at $39.68M.

    Peer Comparison

    XWEL's revenue growth of -7.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    XWELL (XWEL)$5.62MN/A0.2x-82.9%N/A-7.1%0.00%
    bioAffinity Technologies, Inc. (BIAF)$4.00MN/A0.3x-278.9%-376.1%-26.0%0.00%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    iSpecimen Inc (ISPC)$1.66MN/A1.8x0.0%N/A-78.7%0.00%
    WORK Medical Technology Group LTD Ordinary Shares (WOK)$5.36MN/AN/A-41.9%-17.8%19.1%0.00%
    Wellchange Holdings Company Limited (WCT)$7.67MN/A0.2x0.0%N/A-44.1%0.00%
    Nuwellis Inc (NUWE)$2.65MN/AN/A-125.6%N/A14.1%0.00%
    XTL Biopharmaceuticals Ltd ADR (XTLB)$3.93MN/A4.0x0.0%N/A0.0%0.00%
    Precipio Inc (PRPO)$39.68MN/A1.3x-4.1%-5.7%8.3%0.00%
    Jaguar Animal Health Inc (JAGX)$5.59MN/AN/A-130.8%-98.4%-58.9%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Beyond Air Inc (XAIR)$3.55MN/A0.5x0.0%-113.5%0.5%0.00%
    Peer median$5.09MN/A0.9x-2.1%-98.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to XWELL, ranked by how closely their business, size, sector and industry match. The largest groups, 4 each of the 12, are in Biotechnology and Diagnostics & Research; the other 4 span 2 industries.

    CompanyAboutPeers
    bioAffinity Technologies, Inc. (BIAF)Diagnostics & Research
    bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer.
    BIAF competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors
    iSpecimen Inc (ISPC)Diagnostics & Research
    iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids...
    ISPC competitors
    WORK Medical Technology Group LTD Ordinary Shares (WOK)Medical Devices
    WORK Medical Technology Group Ltd is a pioneering player in the medical technology sector, dedicated to the advancement of healthcare through the research...
    Wellchange Holdings Company Limited (WCT)Software - Application
    Wellchange Holdings Company Limited (WCT) is a progressive player in the healthcare and wellness sector...
    Nuwellis Inc (NUWE)Medical Devices
    Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy.
    NUWE competitors
    XTL Biopharmaceuticals Ltd ADR (XTLB)Biotechnology
    XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment...
    Precipio Inc (PRPO)Diagnostics & Research
    Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market.
    PRPO competitors
    Jaguar Animal Health Inc (JAGX)Biotechnology
    Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset...
    JAGX competitors
    Exicure Inc (XCUR)Biotechnology
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    Skye Bioscience, Inc. Common Stock (SKYE)Biotechnology
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Beyond Air Inc (XAIR)Medical Devices
    Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems.
    XAIR competitors

    Frequently Asked Questions About XWEL

    Who are XWELL's main competitors?

    The companies most similar to XWELL include bioAffinity Technologies (BIAF), MDxHealth SA (MDXH), iSpecimen (ISPC), WORK Medical Technology Group LTD Ordinary Shares (WOK) and Wellchange Holdings Company (WCT), listed from the closest match.

    Who is XWELL's biggest competitor?

    Precipio (PRPO) is the largest of the similar companies at $39.68M; bioAffinity Technologies (BIAF) is the closest match by business profile, size, sector and industry.

    How does XWEL stock compare with its competitors?

    XWEL's P/S is 0.2x against a peer median of 0.9x; its net margin is -82.9% against a peer median of -2.1%.

    Which of XWELL's competitors pays a higher dividend?

    XWELL pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is XWELL bigger than its competitors?

    No. XWELL is 5th by market cap among the 13 companies on this page; the largest is Precipio (PRPO) at $39.68M.